A study of the association between the sFlt-1/PIGF ratio and preeclampsia in Xinjiang Uygur Autonomous Region of China
Source abstract
Abstract
AIM: It was previously reported that the ratio of soluble fms-like tyrosine kinase-1 (sFlt-1) to placental growth factor (PlGF) can predict the clinical onset of preeclampsia. This study seeks to validate the association between ratios of sFlt-1/PlGF with preeclampsia and to identify the contribution of ethnicity across diverse populations of the Xinjiang Uygur Autonomous Region. METHODS: Pregnant women were classified into those with preeclampsia (n = 136) and healthy controls (n = 350). Serum levels of sFlt-1 and PlGF were quantified using a Roche serum instrument in both patients and controls. RESULTS: Compared to healthy controls, women with preeclampsia had significantly higher levels of sFlt-1 (7303.81 pg/ml vs. 2508.69 pg/ml, p < .001) and ratios of sFlt-1/PlGF (241.68 vs. 14.29, p < .001), whereas levels of PIGF were decreased (241.68 vs. 14.29, p < .001). These three values varied greatly across nationalities, and non-Han Chinese subjects (including Uygur, Kazak, Hui) were more likely to experience severe preeclampsia than Han Chinese subjects. CONCLUSIONS: This is the first study to demonstrate that the ratio of sFlt-1/PlGF can both predict and serve as a diagnostic factor for preeclampsia in pregnant women from different populations within the Xinjiang region of China.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Pregnancy and preeclampsia studies · Reproductive System and Pregnancy · Maternal and fetal healthcare
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
The First Affiliated Hospital of Medical College of Xi'an Jiaotong University
The Xinjiang Uygur Autonomous Region Maternal and Child Health Care Hospital
The National Engineering Research Center for Miniaturized Detection Systems, Northwest University
Institution of Basic Medical Science, Xi'an Medical University
References (30)
Show source-provided references
1. 10.1093/cvr/cvu01810.1093/cvr/cvu018 ↗
2. 10.1159/00033666210.1159/000336662 ↗
3. 10.1016/S0140-6736(05)17987-210.1016/S0140-6736(05)17987-2 ↗
4. 10.1101/cshperspect.a02347310.1101/cshperspect.a023473 ↗
5. 10.1016/S0140-6736(06)68397-910.1016/S0140-6736(06)68397-9 ↗
6. 10.1155/2011/48109510.1155/2011/481095 ↗
7. 10.1186/1477-7827-7-7010.1186/1477-7827-7-70 ↗
8. 10.3390/ijms16092303510.3390/ijms160923035 ↗
9. 10.1016/j.clinbiochem.2010.02.01010.1016/j.clinbiochem.2010.02.010 ↗
10. 10.1056/NEJMoa03188410.1056/NEJMoa031884 ↗
11. 10.1016/j.ejogrb.2004.11.01510.1016/j.ejogrb.2004.11.015 ↗
12. 10.1373/clinchem.2004.03671510.1373/clinchem.2004.036715 ↗
13. 10.1097/01.AOG.0000264552.85436.a110.1097/01.AOG.0000264552.85436.a1 ↗
14. 10.2174/09298670878388530910.2174/092986708783885309 ↗
15. 10.1016/j.medici.2016.11.00810.1016/j.medici.2016.11.008 ↗
16. 10.1038/nm142910.1038/nm1429 ↗
17. 10.1056/NEJMoa141483810.1056/NEJMoa1414838 ↗
18. 10.1161/CIRCULATIONAHA.111.05436110.1161/CIRCULATIONAHA.111.054361 ↗
19. 10.1016/j.ajog.2011.07.03710.1016/j.ajog.2011.07.037 ↗
20. 10.1161/HYPERTENSIONAHA.113.0178710.1161/HYPERTENSIONAHA.113.01787 ↗
21. 10.1016/j.preghy.2013.02.00310.1016/j.preghy.2013.02.003 ↗
22. Gilstrap L, Ramin S. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia; 2002;77:67–75.
23. 10.1056/NEJMra05043510.1056/NEJMra050435 ↗
24. 10.1016/j.ejogrb.2016.02.01310.1016/j.ejogrb.2016.02.013 ↗
25. Zhang J, Klebanoff MA, Roberts JM. Prediction of adverse outcomes by common definitions of hypertension in pregnancy. Obstetr Gynecol. 2001;97:261–267.
26. 10.1007/s11553-011-0324-z10.1007/s11553-011-0324-z ↗
27. Perales A, Delgado JL, De La Calle M, et al. sFlt-1/PlGF for early-onset pre-eclampsia prediction: STEPS (study of early pre-eclampsia in Spain). Ultrasound Obstetr Gynecol. 2016;50:373–382.
28. 10.1016/S0140-6736(00)03577-710.1016/S0140-6736(00)03577-7 ↗
29. Pegoraro RJ, Ranjith N. Plasminogen activator inhibitor type 1 (PAI-1) and platelet glycoprotein IIIa (PGIIIa) polymorphisms in young Asian Indians with acute myocardial infarction. Cardiovasc J S Afr. 2005;16:266–270.
30. El Sahly HM, Reich RA, Dou SJ, et al. The effect of mannose binding lectin gene polymorphisms on susceptibility to tuberculosis in different ethnic groups. Infect Dis. 2004;36:106–108.